Investigation of genetic and epigenetic signatures of primary and metastatic cancer (melanoma and colorectal cancer)

A postgraduate research opportunity at the University of Otago.

Details

Academic background

Sciences, Health Sciences

Host campus

Dunedin

Qualifications

Postgraduate Certificate, Postgraduate Diploma, Honours, Master’s, PhD

Department

Pathology (Dunedin)

Supervisors

Associate Professor Aniruddha Chatterjee, Dr Euan Rodger

Overview

If you would like to join our lab to perform cutting edge research while collaborating with top clinicians in New Zealand and internationally, please enquire to find out more.

The aim of this theme is to identify progressive epigenetic changes responsible for or involved in cancer metastasis. There is substantial interest in developing methylation-based biomarkers (as these are DNA based, they are stable and easily measurable). Further, unlike genetic changes, epigenetic changes are reversible and the growing efforts to develop combinatorial therapies (e.g. immunotherapy with epigenetic therapies) are already showing promising results. Improved understanding of functional epigenetic changes would significantly contribute to develop early cancer detection strategies and new epigenetic therapies to enhance patient outcomes.

Useful information

• Graduate research at the University of Otago
• Scholarships at the University of Otago

Similar research opportunities

• Analysing gene expression in early Xenopus embryos
• Analysis of cancer genome atlas data to identify epigenetic signature of tumour metastasis
• Analysis of cancer genome atlas data to identify epigenetic signature of tumour metastasis
• Cancer cell invasion: Defining mechanisms underpinning deregulation of the Fn14 signalling axis
• Contribution of a p53 isoform, Δ133p53, in the progress of IBD and initiation of colorectal cancer